Clinical Study to Evaluate Efficacy and Safety of DA-1229 in Patients With CAVD

NCT04055883 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

228

Enrollment

INDUSTRY

Sponsor class

Conditions

Calcific Aortic Valve Disease

Interventions

DRUG: DA-1229

Sponsor

Dong-A ST Co., Ltd.